500 likes | 729 Views
Headache, Blurred Vision, Convulsions, Loss of Consciousness or Elevated Blood Pressure. Advances in Maternal and Neonatal Health. Session Objectives. Discuss best practices for diagnosing and managing hypertension, pre-eclampsia and eclampsia Describe strategies for controlling hypertension
E N D
Headache, Blurred Vision, Convulsions, Loss of Consciousness or Elevated Blood Pressure Advances in Maternal and Neonatal Health
Session Objectives • Discuss best practices for diagnosing and managing hypertension, pre-eclampsia and eclampsia • Describe strategies for controlling hypertension • Describe strategies for preventing and treating convulsions in pre-eclampsia and eclampsia Headaches, Elevated Blood Pressure and Convulsions
Problem • Pregnant or recently postpartum woman who: • Has elevated blood pressure • Complains of headache or blurred vision • Is found unconscious or convulsing Headaches, Elevated Blood Pressure and Convulsions
Elevated Blood Pressure • Classifications: • Chronic hypertension • Pregnancy-induced hypertension • Pregnancy-induced hypertension without proteinuria • Mild pre-eclampsia • Severe pre-eclampsia • Eclampsia Headaches, Elevated Blood Pressure and Convulsions
Pre-Eclampsia • Woman over 20 weeks gestation with: • Diastolic blood pressure > 90 mm Hg AND • Proteinuria • Predisposes woman to develop eclampsia Headaches, Elevated Blood Pressure and Convulsions
Mild Pre-eclampsia • Two readings of diastolic blood pressure 90-110 mm Hg 4 hours apart after 20 weeks gestation • Proteinuria up to 2+ • No other signs/symptoms of severe pre-eclampsia Headaches, Elevated Blood Pressure and Convulsions
Other signs and symptoms sometimes present: Epigastric tenderness Headache Visual changes Hyperreflexia Pulmonary edema Oliguria Severe Pre-eclampsia • Diastolic blood pressure > 110 mm Hg • Proteinuria > 3+ Headaches, Elevated Blood Pressure and Convulsions
Predicting Pre-eclampsia Using Risk Factors: Study Objective and Design • Objective: To determine if risk factors for pre-eclampsia could be used to predict who develops it • Design: Combined retrospective and prospective analysis Headaches, Elevated Blood Pressure and Convulsions Saudan et al 1998.
Predicting Pre-eclampsia Using Risk Factors: Study Definitions • Gestational hypertension was defined as the onset of hypertension (systolic blood pressure > 140 mm Hg and/or diastolic blood pressure > 90 mm Hg) after 20 weeks gestation • Pre-eclampsia was diagnosed by standard criteria Headaches, Elevated Blood Pressure and Convulsions Saudan et al 1998.
Predicting Pre-eclampsia Using Risk Factors: Results No significant difference in age, parity, gestational age, diastolic blood pressure at presentation or history of diabetes. Headaches, Elevated Blood Pressure and Convulsions Saudan et al 1998.
Predicting Pre-eclampsia Using Risk Factors: Conclusion Those women who developed gestational hypertension at an earlier gestational age were more likely to progress to pre-eclampsia. Headaches, Elevated Blood Pressure and Convulsions
Gestational Hypertension and Predicting Pre-eclampsia: Objective and Design • Objective: To determine if there is a “cut off” level of blood pressure which can be used to predict pre-eclampsia • Design: Cohort study; Blood pressure was recorded in 1000 consecutive pregnancies at each antenatal visit until delivery and at the postpartum visit Moutquin et al 1985. Headaches, Elevated Blood Pressure and Convulsions
Gestational Hypertension and Predicting Pre-eclampsia: Results Moutquin et al 1985. Headaches, Elevated Blood Pressure and Convulsions
Gestational Hypertension and Predicting Pre-eclampsia: Conclusions • Approximately 15–25% of women initially diagnosed with gestational hypertension will develop pre-eclampsia • It is difficult to predict who will develop pre-eclampsia Moutquin et al 1985; Saudan 1998. Headaches, Elevated Blood Pressure and Convulsions
Eclampsia • Convulsions occurring after 20 weeks gestation in a woman without a previously known seizure disorder • A small proportion of women with eclampsia have normal blood pressure Headaches, Elevated Blood Pressure and Convulsions
Antenatal care and recognition of hypertension Identification and treatment of pre-eclampsia by skilled attendant Timely delivery 3.4% of women with severe pre-eclampsia will have a convulsion Eclampsia is the number one cause of in-hospital maternal death in Nepal Strategies for Preventing Eclampsia Headaches, Elevated Blood Pressure and Convulsions
Predicting Eclampsia Study: Objective and Design • Objective: Investigate potential usefulness of average mean arterial pressure, maximum mean arterial pressure and maximum diastolic pressure in the second trimester to predict the development of pre-eclampsia • Design: Retrospective analysis Chesley and Sibai 1987. Headaches, Elevated Blood Pressure and Convulsions
Predicting Eclampsia Study: Results • 207 nulliparas and 20 multiparas developed eclampsia • Average mean arterial pressure in 2nd trimester 90 mm Hg: • 22% of nulliparas • 30% of multiparas • Maximum mean arterial pressure in 2nd trimester 90 mm Hg: • 34% nulliparas • 35% multiparas • Maximum diastolic pressure 80 mm Hg: • 8.2% nulliparas • 30% multiparas • Maximum diastolic pressure 90 mm Hg: • 0% nulliparas • 5% multiparas Chesley and Sibai 1987. Headaches, Elevated Blood Pressure and Convulsions
Predicting Eclampsia Study: Conclusions • Cannot use 2nd trimester mean arterial pressure or diastolic pressure to predict eclampsia • Eclampsia is abrupt in onset, without warning signs in about 20% of women Headaches, Elevated Blood Pressure and Convulsions
Initial Assessment and Management of Eclampsia • Shout for help - mobilize personnel • Rapidly evaluate breathing and state of consciousness • Check airway, blood pressure and pulse • Position on left side • Protect from injury but do not restrain • Start IV infusion with large bore needle (16-gauge) • Give oxygen at 4 L/minute DO NOT LEAVE THE WOMAN UNATTENDED Headaches, Elevated Blood Pressure and Convulsions
Hydralazine Labetolol Nifedipine Principles: Initiate antihypertensives if diastolic blood pressure > 110 mm Hg Maintain diastolic blood pressure 90-100 mm Hg to prevent cerebral hemorrhage Antihypertensive Drugs Headaches, Elevated Blood Pressure and Convulsions
Management During a Convulsion • Give magnesium sulfate IM • Gather emergency equipment (O2, mask, etc) • Position on left side • Protect from injury but do not restrain DO NOT LEAVE THE WOMAN UNATTENDED Headaches, Elevated Blood Pressure and Convulsions
Anticonvulsive Drugs • Magnesium sulfate • Diazepam • Phenytoin Headaches, Elevated Blood Pressure and Convulsions
Post-convulsion Management • Prevent further convulsions • Control blood pressure • Prepare for delivery (if undelivered) Headaches, Elevated Blood Pressure and Convulsions
Studies to be Reviewed For severe pre-eclampsia • Magnesium sulfate vs. placebo For eclampsia • Magnesium sulfate vs. diazepam • Magnesium sulfate vs. phenytoin • Magnesium sulfate and outcome of labor Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate • Use magnesium sulfate in • Women with eclampsia • Women with severe pre-eclampsia necessitating delivery • Start magnesium sulfate when decision for delivery is made • Continue therapy until 24 hours after delivery or the last convulsion, whichever occurs last Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Placebo in Women With Pre-Eclampsia: Objective and Design • Objective: To evaluate the effectiveness of magnesium sulfate vs. placebo • Design: Double-blinded prospective randomized controlled trial • Tertiary referral obstetrics unit in South Africa • 822 women with severe pre-eclampsia necessitating delivery randomly assigned to placebo or magnesium sulfate • Data from 699 women evaluated Coetzee, Domisse and Anthony 1998. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Placebo in Women With Pre-Eclampsia: Results • In women with severe pre-eclampsia, eclampsia occurred 11 times less often in women receiving magnesium sulfate than in women receiving placebo Coetzee, Domisse and Anthony 1998. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Placebo in Women With Pre-Eclampsia: Results (continued) * RR 0.09, 95% CI (0.01–0.69) Coetzee, Domisse and Anthony 1998. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Placebo in Women With Pre-Eclampsia: Results (continued) No significant difference in: • Need for antihypertensive therapy • Number of cesarean sections performed • Number of Live births vs. stillbirths • Average gestational age • Birthweight at delivery • Number of maternal deaths Coetzee et al 1998. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Diazepam for Eclampsia: Study Objective and Design • Objective: To assess effects of magnesium sulfate compared with diazepam when used for the care of women with eclampsia • Design: Randomized controlled trial Duley and Henderson-Smart 2000a. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Diazepam: Recurrence of Convulsions RR 0.45, 95% CI 0.35-0.58 No differences in maternal morbidity and borderline decrease in maternal mortality Duley and Henderson-Smart 2000a. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Phenytoin for Eclampsia: Study Objective and Design • Objective: To assess the effects of magnesium sulfate compared with phenytoin when used for the care of women with eclampsia • Design: Randomized controlled trial Duley and Henderson-Smart 2000b. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Phenytoin: Results • 4 trials, 823 women • Magnesium sulfate was associated with a reduction in the recurrence of convulsion when compared to phenytoin (RR 0.30, 95% CI 0.20–0.46) • Magnesium sulfate was also associated with reduced risks of pneumonia (RR 0.66, 95% CI 0.49–0.90) and intensive care unit stay (RR 0.67, 95% CI 0.50–0.89) • Magnesium sulfate reduced the need for babies’ admission to intensive care unit, reduced duration of stay or death in intensive care unit Duley and Henderson-Smart 2000b. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Phenytoin: Recurrence of Convulsions RR 0.30 95% CI 0.20–0.46 Duley and Henderson-Smart 2000b. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Phenytoin: Pneumonia RR 0.44 95% CI 0.24–0.79 Duley and Henderson-Smart 2000b. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Phenytoin: Admission to Neonatal Intensive Care Unit RR 0.67 95% CI 0.50–0.89 Duley and Henderson-Smart 2000b. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate vs. Phenytoin for Eclampsia: Conclusion Magnesium sulfate appears to be substantially more effective and safer than phenytoin for treatment of eclampsia Duley and Henderson-Smart 2000b. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate and Outcome of Labor: Objective and Design • Objective: To evaluate the outcome of labor in women receiving magnesium sulfate vs. phenytoin. • Design: 2138 women were randomly assigned to magnesium sulfate or phenytoin for prevention of eclampsia • 905 nulliparous women met the inclusion criteria: • 480 women received phenytoin • 425 women received magnesium sulfate Headaches, Elevated Blood Pressure and Convulsions Leveno et al 1998.
Magnesium Sulfate and Outcome of Labor: Results Headaches, Elevated Blood Pressure and Convulsions Leveno et al 1998.
Magnesium Sulfate and Outcome of Labor: Conclusion • There is no clinical evidence that magnesium sulfate given for intrapartum management of pregnancy-induced hypertension had any effect on the outcome of labor Headaches, Elevated Blood Pressure and Convulsions Leveno et al 1998.
Magnesium Sulfate and Effect on Labor: Objective and Design • Objective: Evaluate effect of magnesium sulfate on labor • Design: • Study period: March 1995 to June 1996; randomized term mildly pre-eclamptic women to receive magnesium sulfate 6 g bolus then 2 g/hour or saline • Cervical ripening agents/oxytocin at physician’s discretion • Women taken off protocol if developed severe pre-eclampsia Witlin, Friedman and Sibai 1997. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate and Effect on Labor: Results • Outcome: Length of labor, duration of latent and active phases, first and second stages • Results: • No difference in duration of oxytocin: magnesium sulfate group 14.1 hours vs. 13.5 hours • Slightly higher dose of oxytocin required in magnesium sulfate group: 13.9 mU/min vs. 11.0 (p=0.036) • No significant postpartum hemorrhage or side effects Witlin, Friedman and Sibai 1997. Headaches, Elevated Blood Pressure and Convulsions
Magnesium Sulfate and Effect on Labor: Conclusion Slightly higher doses of oxytocin required in magnesium treated groups, but no difference in labor and no adverse effects Witlin, Friedman and Sibai 1997. Headaches, Elevated Blood Pressure and Convulsions
Monitoring Hourly Headaches, Elevated Blood Pressure and Convulsions
Monitoring Hourly Headaches, Elevated Blood Pressure and Convulsions
Principles of Management • Timing and route of delivery: condition of mother vs. maturity of fetus • Assessment of fetus: evidence of fetal compromise • Control of convulsions • Control of hypertension • Referral due to other organ complications: pulmonary, renal, central nervous system Headaches, Elevated Blood Pressure and Convulsions
Summary • There are many manifestations of increased blood pressure in pregnancy • It is not possible to predict which patients are at risk for severe pre-eclampsia or eclampsia • Vigilant care is needed to make the diagnosis • Once the diagnosis is made, appropriate treatment can reduce morbidity and mortality • Anticonvulsants should be used, with magnesium sulfate being the first line • Antihypertensives should be employed as needed • Close monitoring is needed for side effects Headaches, Elevated Blood Pressure and Convulsions
References American College of Obstetricians an Gynecologists. 1996. Technical Bulletin Hypertension in Pregnancy. #219. Chesley LC and BM Sibai. 1987. Blood pressure in mid-trimester and future eclampsia. Am J Obstet Gynecol 157(5): 1258–1561. Coetzee E, J Dommisse and J Anthony. 1998. A randomised controlled trial of intravenous magnesium sulphate versus placebo in the management of women with severe pre-eclampsia. Br J Obstet Gynaecol 105: 300–303. Duley L and D Henderson-Smart. 2000a. Magnesium sulphate versus diazepam for eclampsia (Cochrane Review), in The Cochrane Library, Issue 4. Update Software: Oxford. Duley L and D Henderson-Smart. 2000b. Magnesium sulphate versus phenytoin for eclampsia (Cochrane Review), in The Cochrane Library, Issue 4. Update Software: Oxford. Headaches, Elevated Blood Pressure and Convulsions
References (continued) Leveno KJ et al. 1998. Does magnesium sulfate given for prevention of eclampsia affect the outcome of labor? Am J Obstet Gynecol 178(4): 707–712. Moutquin J et al. 1985. A prospective study of blood pressure in pregnancy: Prediction of preeclampsia. Am J Obstet Gynecol 151: 191–196. Saudan P et al. 1998. Does gestational hypertension become pre-eclampsia? Br J Obstet Gynaecol 105: 1177-1184. Szal SE, MS Croughan-Minihane and SJ Kilpatrick. 1999. Effect of magnesium prophylaxis and preeclampsia on the duration of labor. Am J Obstet Gynecol 180: 1475–1479. Villar MA and BM Sibai. 1989. Clinical significance of elevated mean arterial blood pressure in second trimester and threshold increase in systolic and diastolic blood pressure during third trimester. Am J Obstet Gynecol 160: 419–423. Witlin AG, SA Friedman and BM Sibai. 1997. The effect of magnesium sulfate on the duration of labor in women with mild preeclampsia at term: a randomized, double-blind, placebo-controlled trial. Am J Obstet Gynecol 176(3): 623–627. Headaches, Elevated Blood Pressure and Convulsions